stoxline Quote Chart Rank Option Currency Glossary
  
Tesaro, Inc. (TSRO)
  0 (0%)    06-28 18:07
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-02-29 4:46:39 PM
Short term     
Mid term     
Targets 6-month :  6.4 1-year :  7.48
Resists First :  5.48 Second :  6.4
Pivot price 4.7
Supports First :  4.67 Second :  4.17
MAs MA(5) :  4.91 MA(20) :  4.67
MA(100) :  3.7 MA(250) :  4.29
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  72.6 D(3) :  75
RSI RSI(14): 55.9
52-week High :  6.11 Low :  2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ STRO ] has closed below upper band by 29.1%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.22 - 5.24 5.24 - 5.27
Low: 4.77 - 4.81 4.81 - 4.84
Close: 4.86 - 4.91 4.91 - 4.95
Company Description

Headline News

Mon, 26 Feb 2024
GlaxoSmithKline's Bold Move: Acquiring Tesaro Inc. for $5.1 Billion to Bolster Oncology Portfolio - BNN Breaking

Wed, 05 May 2021
Agreement to acquire TESARO - GSK

Sun, 09 Dec 2018
CLASS ACTION UPDATE for AQUA, TSRO, MDR and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on ... - GlobeNewswire

Mon, 03 Dec 2018
Tesaro Stock Soars After Announcing Agreeing to Be Bought By Glaxosmithkline - Warrior Trading News

Mon, 03 Dec 2018
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company - GSK

Wed, 24 Oct 2018
TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Industry:
Shares Out 61 (M)
Shares Float 40 (M)
Held by Insiders 1 (%)
Held by Institutions 97.6 (%)
Shares Short 2,610 (K)
Shares Short P.Month 2,360 (K)
Stock Financials
EPS -2.92
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.85
Profit Margin 0 %
Operating Margin -260.1 %
Return on Assets (ttm) -27.3 %
Return on Equity (ttm) -100.9 %
Qtrly Rev. Growth -32.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.79
EBITDA (p.s.) -2.88
Qtrly Earnings Growth 0 %
Operating Cash Flow -150 (M)
Levered Free Cash Flow -81 (M)
Stock Valuations
PE Ratio -1.69
PEG Ratio 0.1
Price to Book value 2.65
Price to Sales 6.15
Price to Cash Flow -2.01
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android